ProCertus BioPharm develops and commercializes pharmaceutical products that prevent the common side effects of cancer therapy.
Company (Alive / Active)
505 South Rosa Road
Suite 175 B
Wisconsin, United States
|Investor||Investor Type||Location||Participating Rounds|
|Princeton, New Jersey, United States||Acquired||Pharmasset is a clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections. Pharmasset's primary focus is the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. Pharmasset's research and development efforts are focused on nucleoside/tide analogs, a class of compounds which act as alternative substrates for the viral polymerase, thus inhibiting viral replication. In January 2012, Pharm...Show all||Login to see details|
|Santa Monica, California, United States||Acquired||Agensys, Inc. is developing a pipeline of therapeutic fully human monoclonal antibodies (MAbs) to treat solid tumor cancers based on its own proprietary targets. The Company has discovered and validated a rich portfolio of novel, clinically relevant cancer targets to 14 different cancer types that have been carefully selected to enable development of new effective therapeutics with fewer and less severe side effects. All of Agensys' cancer targets must meet the following criteria: (1) a novel mo...Show all||Login to see details|